JP2014523252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014523252A5 JP2014523252A5 JP2014520633A JP2014520633A JP2014523252A5 JP 2014523252 A5 JP2014523252 A5 JP 2014523252A5 JP 2014520633 A JP2014520633 A JP 2014520633A JP 2014520633 A JP2014520633 A JP 2014520633A JP 2014523252 A5 JP2014523252 A5 JP 2014523252A5
- Authority
- JP
- Japan
- Prior art keywords
- dendritic cell
- functionally equivalent
- tolerogenic dendritic
- equivalent variant
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11382240A EP2557089A2 (en) | 2011-07-15 | 2011-07-15 | Compositions and methods for immunomodulation |
| EP11382240.7 | 2011-07-15 | ||
| PCT/EP2012/063932 WO2013010998A2 (en) | 2011-07-15 | 2012-07-16 | Compositions and methods for immunomodulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017130703A Division JP2017221196A (ja) | 2011-07-15 | 2017-07-03 | 免疫調節のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014523252A JP2014523252A (ja) | 2014-09-11 |
| JP2014523252A5 true JP2014523252A5 (enExample) | 2015-09-03 |
| JP6290078B2 JP6290078B2 (ja) | 2018-03-07 |
Family
ID=45563648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520633A Active JP6290078B2 (ja) | 2011-07-15 | 2012-07-16 | 免疫調節のための組成物および方法 |
| JP2017130703A Pending JP2017221196A (ja) | 2011-07-15 | 2017-07-03 | 免疫調節のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017130703A Pending JP2017221196A (ja) | 2011-07-15 | 2017-07-03 | 免疫調節のための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10106589B2 (enExample) |
| EP (3) | EP2557089A2 (enExample) |
| JP (2) | JP6290078B2 (enExample) |
| AU (1) | AU2012285852B2 (enExample) |
| CA (1) | CA2841994C (enExample) |
| DK (1) | DK2731963T3 (enExample) |
| ES (1) | ES2581278T3 (enExample) |
| PL (1) | PL2731963T3 (enExample) |
| WO (1) | WO2013010998A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2557089A2 (en) * | 2011-07-15 | 2013-02-13 | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Compositions and methods for immunomodulation |
| EP2968457B1 (en) * | 2013-03-14 | 2018-08-29 | Baxalta Incorporated | Factor h for transplantation |
| US9724365B2 (en) | 2013-11-18 | 2017-08-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies |
| FR3018819A1 (fr) * | 2014-03-19 | 2015-09-25 | Univ Bourgogne | Traitement de la reponse inflammatoire et dysimmunitaire |
| EP3384923A1 (en) | 2017-04-06 | 2018-10-10 | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | C4bp-based compounds for treating immunological diseases |
| EP3808763A1 (en) * | 2019-10-17 | 2021-04-21 | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Compounds for immunomodulation |
| WO2025172510A1 (en) | 2024-02-15 | 2025-08-21 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Compounds for treating diseases |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0742235B2 (ja) | 1985-11-08 | 1995-05-10 | 三共株式会社 | 自己免疫性疾病の予防・治療剤 |
| CA2049964A1 (en) * | 1990-01-26 | 1991-07-27 | Biogen, Inc. | C4 binding protein fusion proteins |
| EP0512733A2 (en) * | 1991-05-03 | 1992-11-11 | Washington University | Modified complement system regulator |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| US6447796B1 (en) | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
| EP0863913A4 (en) | 1995-08-21 | 2001-04-11 | Univ Duke | METHOD FOR RECOVERING THE DENSITY OF ANTIGENS ON ANTIGENT PRESENTING CELLS |
| US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US6395713B1 (en) | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
| ES2356342T3 (es) | 1998-01-05 | 2011-04-07 | The University Of Washington | Mejora de transporte utilizando agentes de alteración de membrana. |
| WO2000053722A2 (en) | 1999-03-10 | 2000-09-14 | Phogen Limited | Delivery of nucleic acids and proteins to cells |
| US20020130430A1 (en) | 2000-12-29 | 2002-09-19 | Castor Trevor Percival | Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products |
| WO2002087541A1 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Lipid-based formulations for gene transfer |
| US7060498B1 (en) | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| US7141540B2 (en) | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
| WO2004016283A2 (en) * | 2002-08-14 | 2004-02-26 | Avidis Sa | Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| EP1529109A2 (en) * | 2002-08-14 | 2005-05-11 | Avidis SA | Production of multimeric fusion proteins using a c4bp scaffold |
| WO2005051414A1 (en) * | 2003-11-26 | 2005-06-09 | Avidis Sa | Use of c4bp core region as a cd40 agonist |
| WO2005069726A2 (en) * | 2004-01-21 | 2005-08-04 | Case Western Reserve University | Hybrid and chimeric polypeptides that regulate activation of complement |
| EP1790358A1 (en) * | 2005-11-23 | 2007-05-30 | Université de Reims Champagne-Ardennes | Protein constructs designed for targeting and lysis of cells |
| GB0706912D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel viral vaccines |
| WO2009151634A1 (en) * | 2008-06-12 | 2009-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis |
| US8840868B2 (en) * | 2009-02-04 | 2014-09-23 | The Regents Of The University Of Colorado, A Body Corporate | Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles |
| EP2557089A2 (en) * | 2011-07-15 | 2013-02-13 | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Compositions and methods for immunomodulation |
-
2011
- 2011-07-15 EP EP11382240A patent/EP2557089A2/en not_active Withdrawn
-
2012
- 2012-07-16 EP EP16156965.2A patent/EP3048111A1/en not_active Withdrawn
- 2012-07-16 ES ES12735156.7T patent/ES2581278T3/es active Active
- 2012-07-16 PL PL12735156.7T patent/PL2731963T3/pl unknown
- 2012-07-16 WO PCT/EP2012/063932 patent/WO2013010998A2/en not_active Ceased
- 2012-07-16 EP EP12735156.7A patent/EP2731963B1/en active Active
- 2012-07-16 JP JP2014520633A patent/JP6290078B2/ja active Active
- 2012-07-16 DK DK12735156.7T patent/DK2731963T3/en active
- 2012-07-16 AU AU2012285852A patent/AU2012285852B2/en active Active
- 2012-07-16 CA CA2841994A patent/CA2841994C/en active Active
- 2012-07-16 US US14/233,114 patent/US10106589B2/en active Active
-
2017
- 2017-07-03 JP JP2017130703A patent/JP2017221196A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xie et al. | Immunoregulatory effects of stem cell-derived extracellular vesicles on immune cells | |
| Balbi et al. | First characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential | |
| D’Alessio et al. | Reparative T lymphocytes in organ injury | |
| CN110402146A (zh) | 间充质干细胞群、其产物及其用途 | |
| EP2861719B1 (en) | Compositions and methods for diminishing an immune response | |
| JP2015529457A5 (enExample) | ||
| WO2009134429A2 (en) | Methods and compositions for modulating immunological tolerance | |
| Yuan et al. | Crystalline silica-induced proinflammatory interstitial macrophage recruitment through Notch3 signaling promotes the pathogenesis of silicosis | |
| Yuan et al. | Heterogeneity of microglia phenotypes: developmental, functional and some therapeutic considerations | |
| JP2026082951A (ja) | Ｔ細胞 | |
| JP2011523937A5 (enExample) | ||
| JP2017221196A (ja) | 免疫調節のための組成物および方法 | |
| JP2019518003A5 (enExample) | ||
| CN102216448A (zh) | Foxp3+天然杀伤t细胞及免疫相关疾病的治疗 | |
| Bhatt et al. | Biomaterial-assisted local oxygenation safeguards the prostimulatory phenotype and functions of human dendritic cells in hypoxia | |
| Li et al. | “Remodeling the intestinal immune microenvironment”: immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease | |
| US20170283769A1 (en) | Modified Cells Evoking Reduced Immunogenic Responses | |
| Kwiecień et al. | Umbilical cord matrix (wharton jelly) mesenchymal stem cells in next-generation myocardial repair and regeneration: Mechanisms and pre-clinical evidence | |
| Wang et al. | CTLA-4 nanovesicles disrupt dendritic cell-driven CD8 T cell priming for myocardial infarction therapy | |
| Sanati et al. | Circular RNAs: key players in tumor immune evasion | |
| RU2012146542A (ru) | Способ ингибирования репликации вич в клетках млекопитающих и у людей | |
| Dunstan et al. | Therapeutic potential of stem cell-derived extracellular vesicles in aging and regeneration | |
| WO2022194929A1 (en) | Ex-vivo proliferation of human phagocytic cells | |
| Lee et al. | Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats | |
| Lee et al. | Immune Responses Regulated by Exosomal Mechanisms in Cardiovascular Disease |